Cellebrite DI Ltd. (CLBT) EBITDA
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2025-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $78.35M | (m) | (m) | (m) | 16.47% | $13.22M | $173.54M | (m) | $113.88M | (m) | $12.35M |
|---|
| 2024-12-31 | Reported | $67.51M | (m) | (m) | (m) | 16.83% | $8.57M | $132.17M | (m) | $98.42M | (m) | $7.02M |
|---|
| 2023-12-31 | Reported | $43.25M | (m) | (m) | (m) | 13.30% | $5.23M | $102.06M | (m) | $84.39M | (m) | $5.54M |
|---|
| 2022-12-31 | Reported | $10.24M | (m) | (m) | (m) | 3.78% | $6.90M | $20.58M | (m) | $80.62M | (m) | -$45.00K |
|---|
| 2021-12-31 | Reported | $20.83M | (m) | (m) | (m) | 8.46% | $5.11M | $36.05M | (m) | $65.54M | (m) | $10.91M |
|---|
| 2020-12-31 | Reported | $15.1M | (m) | (m) | (m) | 7.75% | $6.18M | $66.51M | (m) | $54.38M | (m) | $5.62M |
|---|
| 2019-12-31 | Reported | $2.56M | (m) | (m) | (m) | 1.49% | $6.21M | $16.13M | (m) | $46.57M | (m) | $3.29M |
|---|